{"id":"https://openalex.org/W2985348673","doi":"https://doi.org/10.1634/theoncologist.2019-0606","title":"Real-World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim-Chester Disease","display_name":"Real-World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim-Chester Disease","publication_year":2019,"publication_date":"2019-11-18","ids":{"openalex":"https://openalex.org/W2985348673","doi":"https://doi.org/10.1634/theoncologist.2019-0606","mag":"2985348673","pmid":"https://pubmed.ncbi.nlm.nih.gov/32043767","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7011668"},"language":"en","primary_location":{"id":"doi:10.1634/theoncologist.2019-0606","doi":"https://doi.org/10.1634/theoncologist.2019-0606","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2019-0606","pdf_url":"https://academic.oup.com/oncolo/article-pdf/25/2/e386/41921219/oncolo_25_2_e386.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/oncolo/article-pdf/25/2/e386/41921219/oncolo_25_2_e386.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035249579","display_name":"Ila Maewal Saunders","orcid":"https://orcid.org/0000-0002-8805-3734","observed_orcids":["https://orcid.org/0000-0002-8805-3734"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ila M. Saunders","raw_affiliation_strings":["Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103099711","display_name":"Aaron Michael Goodman","orcid":"https://orcid.org/0000-0002-6196-9427","observed_orcids":["https://orcid.org/0000-0002-6196-9427"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron M. Goodman","raw_affiliation_strings":["Division of Blood and Marrow Transplantation, Department of Medicine, University of California San Diego, La Jolla, California, USA","Moores Cancer Center, La Jolla, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Blood and Marrow Transplantation, Department of Medicine, University of California San Diego, La Jolla, California, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Moores Cancer Center, La Jolla, California, USA","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, California, USA","Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, California, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5035249579"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":{"value":1450,"currency":"USD","value_usd":1450},"apc_paid":{"value":1450,"currency":"USD","value_usd":1450},"fwci":2.0567,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.86500524,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"25","issue":"2","first_page":"e386","last_page":"e390"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erdheim-chester-disease","display_name":"Erdheim-Chester disease","score":1.0},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.8299999833106995},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9089999794960022},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-langerhans-cell-histiocytosis","display_name":"non-Langerhans cell histiocytosis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.8130000233650208},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.871999979019165},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.7699999809265137},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.8420000076293945},{"id":"https://openalex.org/keywords/uveitis","display_name":"uveitis","score":0.8560000061988831},{"id":"https://openalex.org/keywords/joint-pain","display_name":"joint pain","score":0.8370000123977661},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8560000061988831},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.8500000238418579},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9030495882034302},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.8968062400817871},{"id":"https://openalex.org/C2779945361","wikidata":"https://www.wikidata.org/wiki/Q1349259","display_name":"Erdheim\u2013Chester disease","level":4,"score":0.806771993637085},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7289051413536072},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.6269353032112122},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5901124477386475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5553862452507019},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5548909306526184},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4818516969680786},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3660431504249573},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35210779309272766},{"id":"https://openalex.org/C2780174970","wikidata":"https://www.wikidata.org/wiki/Q1411740","display_name":"Histiocytosis","level":3,"score":0.32914572954177856},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.32277506589889526},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.31455186009407043},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.2294938862323761},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20719173550605774},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.08734825253486633},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.07226532697677612},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077484","descriptor_name":"Vemurafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D031249","descriptor_name":"Erdheim-Chester Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D031249","descriptor_name":"Erdheim-Chester Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1634/theoncologist.2019-0606","doi":"https://doi.org/10.1634/theoncologist.2019-0606","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2019-0606","pdf_url":"https://academic.oup.com/oncolo/article-pdf/25/2/e386/41921219/oncolo_25_2_e386.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5980315","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7011668","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7011668","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7011668","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"},{"id":"pmid:32043767","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32043767","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt0zt3s9nw","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/0zt3s9nw","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Oncologist, vol 25, iss 2","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1634/theoncologist.2019-0606","doi":"https://doi.org/10.1634/theoncologist.2019-0606","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2019-0606","pdf_url":"https://academic.oup.com/oncolo/article-pdf/25/2/e386/41921219/oncolo_25_2_e386.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7810585149","display_name":"Specialized Cancer Center Support Grant","funder_award_id":"P30CA023100","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320312570","display_name":"Jazz Pharmaceuticals","ror":"https://ror.org/055mhsv54"},{"id":"https://openalex.org/F4320318950","display_name":"Actuate Therapeutics","ror":"https://ror.org/0183brd71"},{"id":"https://openalex.org/F4320329568","display_name":"Grifols","ror":"https://ror.org/02ed64f32"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320334461","display_name":"Foundation Medicine","ror":"https://ror.org/02ackr434"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2985348673.pdf","grobid_xml":"https://content.openalex.org/works/W2985348673.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W194494292","https://openalex.org/W2002696404","https://openalex.org/W2011495237","https://openalex.org/W2048815331","https://openalex.org/W2098396375","https://openalex.org/W2126417952","https://openalex.org/W2560475455","https://openalex.org/W2710981357","https://openalex.org/W2770975168","https://openalex.org/W2941747178","https://openalex.org/W6607948569"],"related_works":["https://openalex.org/W4416033291","https://openalex.org/W4389220546","https://openalex.org/W4406203365","https://openalex.org/W4407371837","https://openalex.org/W3029390343","https://openalex.org/W4392814767","https://openalex.org/W2892033127","https://openalex.org/W2984876485","https://openalex.org/W2885589810","https://openalex.org/W4387520710"],"abstract_inverted_index":{"BACKGROUND:":[0],"Erdheim-Chester":[1],"disease":[2],"(ECD)":[3],"is":[4,14,85],"a":[5,29,95,197],"rare":[6],"non-Langerhans":[7],"cell":[8],"histiocytosis.":[9],"The":[10,125,142,155],"BRAF":[11,30,48,213],"inhibitor":[12],"vemurafenib":[13],"approved":[15],"by":[16],"the":[17,45,74,104,129],"U.S.":[18],"Food":[19],"and":[20,172,176,214],"Drug":[21],"Administration":[22],"(FDA)":[23],"for":[24],"patients":[25,50,64,99,131,194],"with":[26,39,70,100,132,204],"ECD":[27,101,133,205],"harboring":[28],"V600E":[31],"mutation.":[32],"Successful":[33],"treatment":[34],"has":[35],"also":[36],"been":[37],"reported":[38],"MEK-targeted":[40],"therapies,":[41],"likely":[42],"because":[43],"of":[44,80,97,110,117,128,147,166,188,192,212],"fact":[46],"that":[47,62,83],"mutant-negative":[49],"harbor":[51],"MEK":[52,215],"pathway":[53],"alterations.":[54],"In":[55,186],"our":[56],"Rare":[57,105],"Tumor":[58,106],"Clinic,":[59],"we":[60],"noted":[61],"these":[63,88,189,221],"have":[65],"frequent":[66],"drug-related":[67],"toxicity,":[68],"consistent":[69],"previous":[71],"reports":[72],"indicating":[73],"need":[75],"to":[76,207,220],"markedly":[77],"lower":[78,222],"doses":[79,211],"interferon-alpha":[81],"when":[82],"agent":[84],"used":[86],"in":[87,163,182],"patients.":[89],"PATIENTS":[90],"AND":[91],"METHODS:":[92],"We":[93],"performed":[94],"review":[96],"ten":[98,130,193],"seen":[102,181],"at":[103,108],"Clinic":[107],"University":[109],"California":[111],"San":[112],"Diego":[113],"receiving":[114],"16":[115],"regimens":[116],"targeted":[118,167],"BRAF,":[119],"MEK,":[120],"or":[121],"combined":[122],"therapies.":[123],"RESULTS:":[124],"median":[126,143],"age":[127],"was":[134,151],"53":[135],"years":[136],"(range,":[137,153],"29-77);":[138],"seven":[139],"were":[140,169,180],"men.":[141],"dose":[144,164],"percentage":[145],"(percent":[146],"FDA-approved":[148],"dose)":[149],"tolerated":[150],"25%":[152],"25%-50%).":[154],"most":[156],"common":[157],"clinically":[158],"significant":[159],"adverse":[160],"effects":[161],"resulting":[162],"adjustments":[165],"therapies":[168],"rash,":[170],"arthralgias,":[171],"uveitis.":[173],"Renal":[174],"toxicity":[175],"congestive":[177],"heart":[178],"failure":[179],"one":[183],"patient":[184],"each.":[185],"spite":[187],"issues,":[190],"eight":[191],"(80%)":[195],"achieved":[196],"partial":[198],"remission":[199],"on":[200],"therapy.":[201],"DISCUSSION:":[202],"Patients":[203],"appear":[206],"require":[208],"substantially":[209],"reduced":[210],"inhibitors":[216],"but":[217],"are":[218],"responsive":[219],"doses.":[223]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-11-22T00:00:00"}